Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G.

N Engl J Med. 2000 Jun 29;342(26):1946-52.

2.
3.

Celecoxib: new indication. Colorectal cancer: no preventive benefit.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):13-5.

PMID:
16548099
4.

A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G; FAP Study Group..

Gut. 2002 Jun;50(6):857-60.

5.

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.

Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ.

N Engl J Med. 2002 Dec 26;347(26):2104-10.

6.

Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.

Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC; Familial Adenomatous Polyposis Study Group..

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7.

7.
8.

Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.

Davies NM, Gudde TW, de Leeuw MA.

Expert Opin Pharmacother. 2001 Jan;2(1):139-52. Review.

PMID:
11336575
10.

[Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].

Sheng JQ, Li SR, Yang XY, Zhang YH, Su H, Yu DL, Yan W, Geng HG.

Zhonghua Yi Xue Za Zhi. 2006 Feb 28;86(8):526-9. Chinese.

PMID:
16681880
11.

The safety and efficacy of celecoxib in children with familial adenomatous polyposis.

Lynch PM, Ayers GD, Hawk E, Richmond E, Eagle C, Woloj M, Church J, Hasson H, Patterson S, Half E, Burke CA.

Am J Gastroenterol. 2010 Jun;105(6):1437-43. doi: 10.1038/ajg.2009.758. Epub 2010 Mar 16.

PMID:
20234350
12.

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS.

Mayo Clin Proc. 1999 Nov;74(11):1095-105.

PMID:
10560596
13.

Celecoxib for the prevention of colorectal adenomatous polyps.

Arber N, Eagle CJ, Spicak J, Rácz I, Dite P, Hajer J, Zavoral M, Lechuga MJ, Gerletti P, Tang J, Rosenstein RB, Macdonald K, Bhadra P, Fowler R, Wittes J, Zauber AG, Solomon SD, Levin B; PreSAP Trial Investigators..

N Engl J Med. 2006 Aug 31;355(9):885-95.

14.

Arthritis drug approved for polyp prevention blazes trail for other prevention trials.

Smigel K.

J Natl Cancer Inst. 2000 Feb 16;92(4):297-9. No abstract available.

PMID:
10675374
15.

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.

JAMA. 1999 Nov 24;282(20):1921-8.

PMID:
10580457
16.

[Effect of celecoxib, a COX-2 inhibitor, in familial adenomatous polyposis].

Wullen B, Mühlhöfer A, Zoller WG.

Z Gastroenterol. 2001 Apr;39(4):335-7. German. No abstract available.

PMID:
11367984
17.

COX-2 inhibition and colorectal cancer.

Koehne CH, Dubois RN.

Semin Oncol. 2004 Apr;31(2 Suppl 7):12-21. Review.

PMID:
15252926
18.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.

Cancer Res. 2000 Jan 15;60(2):293-7.

19.

Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

Chau I, Cunningham D.

N Engl J Med. 2002 Apr 4;346(14):1085-7. No abstract available.

PMID:
11932478
20.

Supplemental Content

Support Center